Bjorn Siteur
5PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 29, 2025
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg
|Jun 24, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko
|Apr 30, 2025
Large-scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness.Catrin Lutz, Xue Chao, Bim de Klein
|Aug 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao
|Nov 30, 2018
Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.Michela Serresi, Bjorn Siteur, Danielle Hulsman
Pageof 1
Frequent Collaborators
4 joint publications
Jos Jonkers
4 joint publications
Jinhyuk Bhin
4 joint publications
Marieke van de Ven
3 joint publications
Lodewyk F A Wessels
3 joint publications
Julia Yemelyanenko
3 joint publications
Xue Chao
3 joint publications
Sjoerd Klarenbeek
3 joint publications
Catrin Lutz
3 joint publications
Daniel Zingg
3 joint publications
Stefano Annunziato
